Asarina Pharma AB (STU:APS) Total Stockholders Equity : €0.15 Mil (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Asarina Pharma AB Total Stockholders Equity?

Asarina Pharma AB's Total Stockholders Equity for the quarter that ended in Dec. 2023 was €0.15 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Asarina Pharma AB's Book Value per Share for the quarter that ended in Dec. 2023 was €0.01. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Asarina Pharma AB's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.61.

Asarina Pharma AB Total Stockholders Equity Historical Data

The historical data trend for Asarina Pharma AB's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asarina Pharma AB Total Stockholders Equity Chart

Asarina Pharma AB Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

11.40

5.17

2.06

1.33

0.15

Asarina Pharma AB Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Dec22	Jun23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial															1.64	1.82	1.33	0.47	0.15

Asarina Pharma AB (STU:APS) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Asarina Pharma AB's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(0.147	-	0)	/	22.6414
	=	0.01

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Asarina Pharma AB's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.089	+	0)	/	0.147
	=	0.61

Asarina Pharma AB Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Asarina Pharma AB's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Asarina Pharma AB (STU:APS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Asarina Pharma AB (STU:APS) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

ASAP:Sweden

Address

Fogdevreten 2, Karolinska Institutet Science Park, Solna, SWE, SE-171 65

Website

https://www.asarinapharma.com

Asarina Pharma AB is a Swedish biotech company developing Sepranolone for Allopregnanolone-related stress, compulsion and neurological disorders. Its product pipeline is built on over 40 years of research into llopregnanolone-related neurological disorders. With the new family of GAMSA compounds (GABA-A Modulating Steroid Antagonists) the company aims to deliver a new generation of efficacious and safe drugs for still widely untreated neuroendocrinological conditions.

Asarina Pharma AB (STU:APS) Headlines

No Headlines